The Cannabist Company Holdings Inc.
The Cannabist Company Holdings Inc. cultivates, manufactures, and provides cannabis products and related services in the United States and internationally. The company operates medical and/or adult use marijuana businesses and dispensaries. It also offers flower, concentrates, edibles, and oils and tablets under the dreamt, Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brand… Read more
The Cannabist Company Holdings Inc. (CBSTF) - Net Assets
Latest net assets as of December 2024: $-30.06 Million USD
Based on the latest financial reports, The Cannabist Company Holdings Inc. (CBSTF) has net assets worth $-30.06 Million USD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($696.17 Million) and total liabilities ($726.23 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-30.06 Million |
| % of Total Assets | -4.32% |
| Annual Growth Rate | N/A |
| 5-Year Change | -109.34% |
| 10-Year Change | N/A |
| Growth Volatility | 75.53 |
The Cannabist Company Holdings Inc. - Net Assets Trend (2019–2024)
This chart illustrates how The Cannabist Company Holdings Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for The Cannabist Company Holdings Inc. (2019–2024)
The table below shows the annual net assets of The Cannabist Company Holdings Inc. from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-30.06 Million | -146.00% |
| 2023-12-31 | $65.35 Million | -68.41% |
| 2022-12-31 | $206.90 Million | -62.44% |
| 2021-12-31 | $550.82 Million | +71.13% |
| 2020-12-31 | $321.88 Million | +20.58% |
| 2019-12-31 | $266.93 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to The Cannabist Company Holdings Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100929900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $1.16 Billion | % |
| Total Equity | $-28.69 Million | 100.00% |
The Cannabist Company Holdings Inc. Competitors by Market Cap
The table below lists competitors of The Cannabist Company Holdings Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Unibap Space Solutions AB (publ)
F:JS8
|
$19.29 Million |
|
Triller Group Inc.
NASDAQ:ILLR
|
$19.29 Million |
|
Better Life Group Co Ltd
TW:1805
|
$19.30 Million |
|
Pan Entertainment Co. Ltd
KQ:068050
|
$19.31 Million |
|
Altech Batteries Ltd
AU:ATC
|
$19.28 Million |
|
GEE Group Inc
NYSE MKT:JOB
|
$19.28 Million |
|
Viewbix Inc. Common Stock
PINK:VBIX
|
$19.28 Million |
|
Filter Vision Public Company Limited
BK:FVC
|
$19.25 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in The Cannabist Company Holdings Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 66,872,000 to -28,694,000, a change of -95,566,000 (-142.9%).
- Net loss of 105,886,000 reduced equity.
- Other factors increased equity by 10,320,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-105.89 Million | -369.02% |
| Other Changes | $10.32 Million | +35.97% |
| Total Change | $- | -142.91% |
Book Value vs Market Value Analysis
This analysis compares The Cannabist Company Holdings Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $1.24 | $0.05 | x |
| 2020-12-31 | $1.24 | $0.05 | x |
| 2021-12-31 | $1.52 | $0.05 | x |
| 2022-12-31 | $0.52 | $0.05 | x |
| 2023-12-31 | $0.16 | $0.05 | x |
| 2024-12-31 | $-0.06 | $0.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently The Cannabist Company Holdings Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -23.08%
- • Asset Turnover: 0.66x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-93.26%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -38.24% | -132.44% | 0.19x | 1.50x | $-129.42 Million |
| 2020 | -32.43% | -61.71% | 0.23x | 2.32x | $-144.93 Million |
| 2021 | -25.04% | -31.10% | 0.33x | 2.41x | $-200.24 Million |
| 2022 | -201.06% | -81.32% | 0.51x | 4.81x | $-436.70 Million |
| 2023 | -262.76% | -34.36% | 0.62x | 12.31x | $-182.40 Million |
| 2024 | 0.00% | -23.08% | 0.66x | 0.00x | $-103.02 Million |
Industry Comparison
This section compares The Cannabist Company Holdings Inc.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| The Cannabist Company Holdings Inc. (CBSTF) | $-30.06 Million | -38.24% | N/A | $19.29 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |